Objectives: Endovascular treatment (EVT) has emerged as the gold standard therapy for stroke due to large vessel occlusion (LVO). There is however limited evidence to suggest that similar efficacy can be expected in elderly patients. We aimed to assess the efficacy and safety of EVT in elderly patients (aged > 80), comparing outcomes to younger patients (aged < 80). Material and Methods: A total of 195 patients with LVO stroke treated with EVT were included and dichotomized by age. We compared neurological improvement, clinical 90 day outcome, technical recanalization rates, procedure-related complications, and mortality in between the groups. Results: Both groups showed equally marked neurological improvement. A favorable outcome modified Rankin Scale (mRS < 2) was seen in 28% of the elderly patients compared to 46% of the younger patients (p = 0.01). mRS 0–3 was seen in 46% of the elderly patients and 58% of the younger patients (p = 0.09). The rates of successful technical recanalization did not differ between the groups and there were no differences in procedural complication rates or incidence of symptomatic intracranial bleeding. Three-month mortality rates were however higher in the elderly group. Conclusions: EVT in the elderly resulted in equally notable neurological improvement as compared to younger patients. Although the elderly had a higher mortality rate and fewer favorable clinical outcomes at 3 month follow-up, a strict upper age limit for EVT seems unjustified.

Keywords:
Stroke, Elderly, Endovascular treatment, Endovascular treatment, Prognosis
1.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
Lancet
. 2012 Dec; 380(9859): 2095–128.
2.
Foerch C, Sitzer M, Steinmetz H, Neumann-Haefelin T; Arbeitsgruppe Schlaganfall Hessen. Future demographic trends decrease the proportion of ischemic stroke patients receiving thrombolytic therapy: a call to set-up therapeutic studies in the very old.
Stroke
. 2009 May; 40(5): 1900–2.
3.
Heuschmann PU, Kolominsky-Rabas PL, Roether J, Misselwitz B, Lowitzsch K, Heidrich J, et al.; German Stroke Registers Study Group. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy.
JAMA
. 2004 Oct; 292(15): 1831–8.
4.
Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al.; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
N Engl J Med
. 2008 Sep; 359(13): 1317–29.
5.
García-Caldentey J, Alonso de Leciñana M, Simal P, Fuentes B, Reig G, Díaz-Otero F, et al. Intravenous thrombolytic treatment in the oldest old.
Stroke Res Treat
. 2012; 2012: 923676.
6.
Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al.; Stroke Thrombolysis Trialists’ Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.
Lancet
. 2014 Nov; 384(9958): 1929–35.
7.
Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al.; MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke.
N Engl J Med
. 2015 Jan; 372(1): 11–20.
8.
Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al.; SWIFT PRIME Investigators. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.
N Engl J Med
. 2015 Jun; 372(24): 2285–95.
9.
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al.; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke.
N Engl J Med
. 2015 Mar; 372(11): 1019–30.
10.
Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al.; EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection.
N Engl J Med
. 2015 Mar; 372(11): 1009–18.
11.
Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al.; REVASCAT Trial Investigators. Thrombectomy within 8 hours after symptom onset in ischemic stroke.
N Engl J Med
. 2015 Jun; 372(24): 2296–306.
12.
Kurre W, Aguilar-Pérez M, Niehaus L, Fischer S, Schmid E, Bäzner H, et al. Predictors of outcome after mechanical thrombectomy for anterior circulation large vessel occlusion in patients aged ≥80 years.
Cerebrovasc Dis
. 2013; 36(5-6): 430–6.
13.
Broussalis E, Weymayr F, Hitzl W, Unterrainer AF, Trinka E, Killer M. Endovascular mechanical recanalization of acute ischaemic stroke in octogenarians.
Eur Radiol
. 2016 Jun; 26(6): 1742–50.
14.
Singer OC, Haring HP, Trenkler J, Nolte CH, Bohner G, Reich A, et al. Age dependency of successful recanalization in anterior circulation stroke: the ENDOSTROKE study.
Cerebrovasc Dis
. 2013; 36(5-6): 437–45.
15.
Duffis EJ, He W, Prestigiacomo CJ, Gandhi CD. Endovascular treatment for acute ischemic stroke in octogenarians compared with younger patients: a meta-analysis.
Int J Stroke
. 2014 Apr; 9(3): 308–12.
16.
Chandra RV, Leslie-Mazwi TM, Oh DC, Chaudhry ZA, Mehta BP, Rost NS, et al. Elderly patients are at higher risk for poor outcomes after intra-arterial therapy.
Stroke
. 2012 Sep; 43(9): 2356–61.
17.
Sallustio F, Koch G, Motta C, Diomedi M, Alemseged F, D’Agostino VC, et al. Efficacy and Safety of Mechanical Thrombectomy in Older Adults with Acute Ischemic Stoke.
J Am Geriatr Soc
. 2017 Aug; 65(8): 1816–20.
18.
Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL, et al.; Cerebral Angiographic Revascularization Grading (CARG) Collaborators; STIR Revascularization working group; STIR Thrombolysis in Cerebral Infarction (TICI) Task Force. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement.
Stroke
. 2013 Sep; 44(9): 2650–63.
19.
Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, et al.; American Heart Association Stroke Council. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.
Stroke
. 2015 Oct; 46(10): 3020–35.
20.
Jagani M, Brinjikji W, Rabinstein AA, Pasternak JJ, Kallmes DF. Hemodynamics during anesthesia for intra-arterial therapy of acute ischemic stroke.
J Neurointerv Surg
. 2016 Sep; 8(9): 883–8.
21.
Yoo AJ, Simonsen CZ, Prabhakaran S, Chaudhry ZA, Issa MA, Fugate JE, et al.; Cerebral Angiographic Revascularization Grading Collaborators. Refining angiographic biomarkers of revascularization: improving outcome prediction after intra-arterial therapy.
Stroke
. 2013 Sep; 44(9): 2509–12.
22.
Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al.; Second European-Australasian Acute Stroke Study Investigators. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II).
Lancet
. 1998 Oct; 352(9136): 1245–51.
23.
Quinn TJ, Dawson J, Lees JS, Chang TP, Walters MR, Lees KR; GAIN and VISTA Investigators. Time spent at home poststroke: “home-time” a meaningful and robust outcome measure for stroke trials.
Stroke
. 2008 Jan; 39(1): 231–3.
24.
Fonarow GC, Liang L, Thomas L, Xian Y, Saver JL, Smith EE, et al. Assessment of Home-Time After Acute Ischemic Stroke in Medicare Beneficiaries.
Stroke
. 2016 Mar; 47(3): 836–42.
25.
Danière F, Lobotesis K, Machi P, Eker O, Mourand I, Riquelme C, et al. Patient selection for stroke endovascular therapy—DWI-ASPECTS thresholds should vary among age groups: insights from the RECOST study.
AJNR Am J Neuroradiol
. 2015 Jan; 36(1): 32–9.
26.
Hwang K, Hwang G, Kwon OK, Kim CH, Ban SP, Han MK, et al. Endovascular Treatment for Acute Ischemic Stroke Patients over 80 Years of Age.
J Cerebrovasc Endovasc Neurosurg
. 2015 Sep; 17(3): 173–9.
27.
To CY, Rajamand S, Mehra R, Falatko S, Badr Y, Richards B, et al. Outcome of mechanical thrombectomy in the very elderly for the treatment of acute ischemic stroke: the real world experience.
Acta Radiol Open
. 2015 Sep 10; 4(9): 2058460115599423.
28.
Azkune Calle I, Bocos Portillo J, Anton-Ladislao A, Gil Garcia A, Gonzalez Diaz E, Gomez-Beldarrain M, et al.; Clinical Outcome of Mechanical Thrombectomy for Stroke in the Elderly. Clinical Outcome of Mechanical Thrombectomy for Stroke in the Elderly.
J Stroke Cerebrovasc Dis
. 2017 Mar; 26(3): 582–8.
29.
Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al.; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.
Lancet
. 2016 Apr; 387(10029): 1723–31.
30.
He AH, Churilov L, Mitchell PJ, Dowling RJ, Yan B. Every 15-min delay in recanalization by intra-arterial therapy in acute ischemic stroke increases risk of poor outcome.
Int J Stroke
. 2015 Oct; 10(7): 1062–7.
31.
Meretoja A, Keshtkaran M, Tatlisumak T, Donnan GA, Churilov L. Endovascular therapy for ischemic stroke: save a minute-save a week.
Neurology
. 2017 May; 88(22): 2123–7.
32.
Advani R, Naess H, Kurz MW. The golden hour of acute ischemic stroke.
Scand J Trauma Resusc Emerg Med
. 2017 May; 25(1): 54.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.